Skip to content

Sarah Xiao

NPI 1386262590ActiveIndividual· Surgery· Apo, AP

Surgery in Apo, Armed Forces Pacific, licensed in NE, with an NPI issued in July 2020. Part D covered 45 prescriptions written in 2024, 96% of them generic. Veloxis Pharmaceuticals, Inc. reported $67.57 in payments in 2025, mostly education.

Overview

NPI1386262590
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJul 14, 2020
Last updated in NPPESJul 13, 2026
Certified by providerJul 13, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Surgery Primary208600000X35363NE

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - General Surgery (NV)

Part D prescriptions in 2024

Prescriptions (claims)45 · 54 30-day fills
Patients23
Total drug cost$1,641
Generic share96% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$67.57 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Veloxis Pharmaceuticals, Inc.$67.571

What the 2025 payments were for

  • Education$67.57 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Surgery providers in Apo

All Surgery providers in Armed Forces Pacific →